Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels
Serum PIVKA-II is an independent prognostic biomarker for patients with HCC who have normal AFP levels and can be used to stratify patients into distinct risk groups.
Authors
- Chien‐Wei Su (ORCID: https://orcid.org/0000-0003-3889-7004)
- Chien‐An Liu (ORCID: https://orcid.org/0000-0002-3594-3629)
- Pei‐Chang Lee (ORCID: https://orcid.org/0000-0002-7492-2484)
- Ming‐Chih Hou (ORCID: https://orcid.org/0000-0002-4886-0718)
- San‐Chi Chen (ORCID: https://orcid.org/0000-0002-9436-5400)
- Jiing‐Chyuan Luo (ORCID: https://orcid.org/0000-0003-4306-5464)
- Kuan‐Jung Huang (ORCID: https://orcid.org/0000-0002-7402-3243)
- I‐Cheng Lee (ORCID: https://orcid.org/0000-0002-9316-4682)
- Yi‐Hsiang Huang (ORCID: https://orcid.org/0000-0001-5241-5425)
- Shu-Cheng Chou
- Chun-Ting Ho
- Jaw‐Ching Wu
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1097/jcma.0000000000001305
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70